Hemodialysis Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Conventional, Daily, Nocturnal), By Product (Equipment, Consumable, Drug, Catheters), By Services (In-Center Dialysis, Home Dialysis), By End User (Hospitals, Dialysis Centers) and Region Forecast 2020-2031

Hemodialysis Market size was valued at US$ size was valued at US$ 92.9 billion in 2024 and is expected to reach US$ 144.3 billion by 2031, growing at a significant CAGR of 6.5% from 2025-2031. Hemodialysis can be treated as an inpatient or outpatient procedure. Regular hemodialysis is carried out in a dialysis outpatient facility, which might be a standalone clinic or a specially designed unit in a hospital. Home hemodialysis is performed less regularly. Dialysis treatments at home can be self-started and managed or done jointly with the assistance of a trained helper, who is typically a family member. Dialysis treatments in a clinic are launched and handled by a specialist staff consisting of nurses and technicians.

The increase in prevalence of kidney failure and chronic renal dysfunction cases. Hemodialysis is a dialysis procedure that filters a patient's blood to eliminate waste products such as urea, creatinine, and excess water. These impurities typically emerge when the kidneys fail or are damaged. Companies in this field generally manufacture dialyzers and dialysis pumping machines, although they can also make other dialysis-related tools like blood pumps, catheters, and tubing kits.  

Key Developments

• In January 2025, Diality, a medical device company specializing in smart, flexible hemodialysis solutions, announced the successful completion of the first-ever patient treatment using the Moda-flx Hemodialysis System™. The milestone was achieved in collaboration with the North America Research Institute at Ontario-Holt Dialysis Center in Ontario, California.
• In November 2024, Quanta Dialysis Technologies® announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the use of its Quanta Dialysis System in the home setting. With this approval, Quanta becomes the only company to offer a high dialysate flow (500 mL/min) system across the entire care continuum for end-stage renal disease (ESRD) patients.
• In October 2024, Nephro Care India Limited (NCIL) announced the development of a prototype for an AI-enabled smart hemodialysis machine with remote monitoring capabilities. Aimed at making renal care more accessible and affordable in India, the project is supported by a grant from the Department of Science and Technology and Biotechnology, West Bengal, and is being developed in collaboration with the National Institute of Technology, Silchar. The new prototype is expected to reduce machine costs by 70-75%, bringing the price down from Rs 7.5-8 lakh to approximately Rs 2 lakh.